These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Apoptotic activity and antitumor efficacy of PEGylated TNF-related apoptosis-inducing ligand (TRAIL) in a Mia Paca-2 cell-xenografted mouse model. Byeon HJ; Choi SH; Choi JS; Kim TH; Lee ES; Lee KC; Youn YS Biomed Pharmacother; 2014 Feb; 68(1):65-9. PubMed ID: 24268811 [TBL] [Abstract][Full Text] [Related]
9. Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer. Smith JP; Kramer S; Bagheri S Pancreas; 1991 Sep; 6(5):551-7. PubMed ID: 1946312 [TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897 [TBL] [Abstract][Full Text] [Related]
11. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor. Freeman JW; Mattingly CA; Strodel WE J Cell Physiol; 1995 Oct; 165(1):155-63. PubMed ID: 7559796 [TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. Litvak DA; Hellmich MR; Evers BM; Banker NA; Townsend CM J Gastrointest Surg; 1998; 2(2):146-50. PubMed ID: 9834410 [TBL] [Abstract][Full Text] [Related]
13. Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2. Ehlers RA; Zhang Y; Hellmich MR; Evers BM Biochem Biophys Res Commun; 2000 Mar; 269(3):704-8. PubMed ID: 10720480 [TBL] [Abstract][Full Text] [Related]
14. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice. Weckbecker G; Raulf F; Bodmer D; Bruns C Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of gut hormones on pancreatic and intestinal growth during administration of an elemental diet. Evers BM; Izukura M; Townsend CM; Uchida T; Thompson JC Ann Surg; 1990 May; 211(5):630-6; discussion 636-8. PubMed ID: 2339923 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice. Radulovic S; Comaru-Schally AM; Milovanovic S; Schally AV Pancreas; 1993 Jan; 8(1):88-97. PubMed ID: 8093555 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2. Yamada M; Ohata H; Momose K; Yamada M; Richelson E Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):37-47. PubMed ID: 8581347 [TBL] [Abstract][Full Text] [Related]
18. Effect of neurotensin on gut mucosal growth in rats with jejunal and ileal Thiry-Vella fistulas. Chung DH; Evers BM; Shimoda I; Townsend CM; Rajaraman S; Thompson JC Gastroenterology; 1992 Oct; 103(4):1254-9. PubMed ID: 1397882 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice. Radulovic S; Nagy A; Szoke B; Schally AV Cancer Lett; 1992 Mar; 62(3):263-71. PubMed ID: 1317746 [TBL] [Abstract][Full Text] [Related]
20. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells. Kawaguchi M; Hosotani R; Kogire M; Ida J; Doi R; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Masui T; Imamura M Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]